Yong Ran

1.2k total citations
30 papers, 832 citations indexed

About

Yong Ran is a scholar working on Physiology, Oncology and Molecular Biology. According to data from OpenAlex, Yong Ran has authored 30 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 11 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Yong Ran's work include Alzheimer's disease research and treatments (13 papers), Drug Transport and Resistance Mechanisms (5 papers) and Cholinesterase and Neurodegenerative Diseases (5 papers). Yong Ran is often cited by papers focused on Alzheimer's disease research and treatments (13 papers), Drug Transport and Resistance Mechanisms (5 papers) and Cholinesterase and Neurodegenerative Diseases (5 papers). Yong Ran collaborates with scholars based in United States, China and Australia. Yong Ran's co-authors include Todd E. Golde, Joo In Jung, Thomas B. Ladd, Christian Lessard, F. Quigley, Nancy R. Forsthoefel, Pedro E. Cruz, Shailender S. Chauhan, Hans J. Bohnert and Donald E. Nelson and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and The EMBO Journal.

In The Last Decade

Yong Ran

26 papers receiving 827 citations

Peers

Countries citing papers authored by Yong Ran

Since Specialization

Citations

This map shows the geographic impact of Yong Ran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Ran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Ran more than expected).

Fields of papers citing papers by Yong Ran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong Ran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Ran. The network helps show where Yong Ran may publish in the future.

Co-authorship network of co-authors of Yong Ran

This figure shows the co-authorship network connecting the top 25 collaborators of Yong Ran. A scholar is included among the top collaborators of Yong Ran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong Ran. Yong Ran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Sirt1‐Piezo1 Axis Promotes Bone Formation and Repair in Mice 2025 ·Advanced Science ·Donghao Gan, Yong Ran, Hong Pan, Qinnan Yan, Wenjing Zhang, Bo Zhou, Peng Xu, (unknown), Haipeng Xue, (unknown), Tailin He, Qingyun Jia, Lei Qin, Francis Y. Lee, Di Chen, Liu C, Guozhi Xiao	0
2	Biomarkers of inflammation and colorectal cancer risk 2025 ·Frontiers in Oncology ·Yuting Li, (unknown), Yong Ran, Furong Lu, You Qin	3
3	Comparative evaluation of pregnancy-related adverse events associated with proton pump inhibitors using the FDA adverse event reporting system database 2025 ·International Journal of Clinical Pharmacy ·(unknown), Yong Ran, (unknown), (unknown), Hailin Liu	0
4	The potential functions of ferroptosis on urinary stones: mechanisms and therapeutic implications 2025 ·Frontiers in Physiology ·Yong Ran, Yuhan Ma, Yaguang Luo, Yajun Ruan	0
5	Developmental dynamics of brain network modularity and temporal co-occurrence diversity in childhood 2024 ·Journal of Affective Disorders ·Zeyu Song, (unknown), Yifei Wang, Yong Ran, Xiaoying Tang, Hanjun Li, Zhenqi Jiang	1
6	γ-Secretase modulators exhibit selectivity for modulation of APP cleavage but inverse γ-secretase modulators do not 2020 ·Alzheimer s Research & Therapy ·Christian Lessard, (unknown), Thomas B. Ladd, Lisa M. Minter, Barbara A. Osborne, Lucio Miele, Todd E. Golde, Yong Ran	7
7	CD28 Signaling Drives Notch Ligand Expression on CD4 T Cells 2020 ·Frontiers in Immunology ·(unknown), Sudarvili Shanthalingam, (unknown), Khushboo Singh, (unknown), (unknown), Rebecca Lawlor, Yong Ran, Todd E. Golde, Lucio Miele, S. Thayumanavan, Lisa M. Minter, Barbara A. Osborne	12
8	Individual and combined presenilin 1 and 2 knockouts reveal that both have highly overlapping functions in HEK293T cells 2019 ·Journal of Biological Chemistry ·Christian Lessard, (unknown), Thomas B. Ladd, Lisa M. Minter, Barbara A. Osborne, Lucio Miele, Todd E. Golde, Yong Ran	13
9	High‐affinity interactions and signal transduction between Aβ oligomers and TREM 2 2018 ·EMBO Molecular Medicine ·Christian Lessard, (unknown), Yingyue Zhou, Thomas B. Ladd, Pedro E. Cruz, Yong Ran, Thomas E. Mahan, (unknown), David M. Holtzman, Jason D. Ulrich, Marco Colonna, Todd E. Golde	104
10	Novel monoclonal antibodies targeting the microtubule-binding domain of human tau 2018 ·PLoS ONE ·Cara L. Croft, Brenda D. Moore, Yong Ran, Paramita Chakrabarty, Yona Levites, Todd E. Golde, Benoit I. Giasson	10
11	A novel panel of α-synuclein antibodies reveal distinctive staining profiles in synucleinopathies 2017 ·PLoS ONE ·(unknown), Cara J. Riffe, Brenda D. Moore, Yong Ran, Paramita Chakrabarty, Todd E. Golde, Benoit I. Giasson	39
12	γ‐Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct 2017 ·EMBO Molecular Medicine ·Yong Ran, Fokhrul Hossain, Antonio Pannuti, Christian Lessard, (unknown), Joo In Jung, Lisa M. Minter, Barbara A. Osborne, Lucio Miele, Todd E. Golde	113
13	The stress response neuropeptide CRF increases amyloid‐β production by regulating γ‐secretase activity 2015 ·The EMBO Journal ·Hyo‐Jin Park, Yong Ran, Joo In Jung, Oliver Wendell Holmes, Ashleigh Price, Lisa Smithson, Carolina Ceballos‐Diaz, Chul Ju Han, Michael S. Wolfe, Yehia Daaka, Andrey E. Ryabinin, Seong‐Hun Kim, Richard L. Hauger, Todd E. Golde, Kevin M. Felsenstein	41
14	Cholestenoic acid, an endogenous cholesterol metabolite, is a potent γ-secretase modulator 2015 ·Molecular Neurodegeneration ·Joo In Jung, Ashleigh Price, Thomas B. Ladd, Yong Ran, (unknown), Carolina Ceballos‐Diaz, Lisa Smithson, Günther Hochhaus, Yufei Tang, (unknown), (unknown), Edward H. Koo, Gideon Shapiro, Kevin M. Felsenstein, Todd E. Golde	16
15	Differential Inhibition of Signal Peptide Peptidase Family Members by Established γ-Secretase Inhibitors 2015 ·PLoS ONE ·Yong Ran, (unknown), Carolina Ceballos‐Diaz, Joo In Jung, Doron C. Greenbaum, Kevin M. Felsenstein, Todd E. Golde	16
16	Independent Relationship between Amyloid Precursor Protein (APP) Dimerization and γ-Secretase Processivity 2014 ·PLoS ONE ·Joo In Jung, (unknown), Pedro E. Cruz, Thomas B. Ladd, (unknown), Edward H. Koo, Kevin M. Felsenstein, Todd E. Golde, Yong Ran	27
17	Induction of CNS α-synuclein pathology by fibrillar and non-amyloidogenic recombinant α-synuclein 2013 ·Acta Neuropathologica Communications ·Amanda N. Sacino, Mieu Brooks, (unknown), (unknown), M. Albert Thomas, Yona Levites, Yong Ran, Todd E. Golde, Benoit I. Giasson	73
18	γ-Secretase Processing and Effects of γ-Secretase Inhibitors and Modulators on Long Aβ Peptides in Cells 2013 ·Journal of Biological Chemistry ·Yong Ran, Pedro E. Cruz, Thomas B. Ladd, Abdul H. Fauq, Joo In Jung, Julian C. Matthews, Kevin M. Felsenstein, Todd E. Golde	18
19	Interactions of the GM2 Activator Protein with Phosphatidylcholine Bilayers: A Site-Directed Spin-Labeling Power Saturation Study 2009 ·Biophysical Journal ·(unknown), Yong Ran, (unknown), Gail E. Fanucci	8
20	Ligand Extraction Properties of the GM2 Activator Protein and Its Interactions with Lipid Vesicles 2009 ·Biophysical Journal ·Yong Ran, Gail E. Fanucci	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact